DISCLAIMER: This news article is a direct translation of the original Korean article from Getnews. BioNote Inc. does not claim any right to the article or claim any ownership.The translation was completed by BioNote Inc. only for the convenience of non-Korean speaking customers and BioNote Inc. does not seek to redistribute nor acquire profit from the translation. BioNotes (CEO Cho Byung-ki), a global leading bio-content and animal diagnosis company, recently launched overseas, announced on the 2nd that its cutting-edge field molecular diagnostic equipment Vcheck M10 (hereinafter M10) received favorable reviews for its technology at the 2022 World Small Animal Society (WSAVA) Congress.The event was held in Lima, Peru from the 29th to the 31st of last month, and received high attention from veterinarians and veterinary diagnostic industry officials around the world for its M10 product's innovative technology, according to BioNote.M10 is an automated device that integrates nucleic acid extraction and nucleic acid amplification (PCR) into one device, which was previously carried out by separate equipments. The M10 has a very simple inspection process, so using this equipment, veterinarians at general veterinary hospitals can conduct PCR tests at animal hospitals without additional training. This is groundbreaking because the PCR confirmation test, which was requested by a professional inspection agency, which took about 1 to 3 days, can be carried out quickly and accurately at field in an hour.M10 has completed the export license of the quarantine headquarters and the European CE certification, and is preparing for domestic use. As a cartridge used in M10 equipment, "Vcheck MEhrlichia/Anaplasma" was launched overseas for the first time in September this year, and "Vcheck M Babesia gibsoni/canis" was developed as the second item and is being prepared for overseas launch in November.BioNote said, "We have confirmed the market's great demand for M10 through the Vcheck M launch show and 2022 WSAVA in Latin America," adding, "BioNote, which has previously shown expertise in immunodiagnosis, aims to become a global leading company that provides total solutions from initial screening tests to PCR confirmation tests."Source : Getnews (http://www.getnews.co.kr) Article Link: https://www.getnews.co.kr/news/articleView.html?idxno=604367
Bionote Webinar on utilizing canine cortisol measurement in clinical practice will be held on Oct 18, 2022 (EST) at 8 ap for 1 hour, 15 minutes. This program has been approved for 1 hour of continuing credit in the jurisdictions which recognize RACE approval. Dr. Nate Chaudoin will present about navigating the diseases of the adrenal gland and learn the value of testing cortisol levels in diagnosing and managing adrenal disease. This webinar will cover the utility of canine cortisol measurement in clinical practice and in the treatment of canine adrenal diseases. Dr. Nate Chaudoin will review canine adrenal disease, including diagnosis treatment and monitoring, as well as the why and when to test in clinical applications. You will be able to learn a basic understanding of adrenal gland structure and function, recognize both typical and atypical canine Addison’s disease, including their presentations and how to diagnose and treat. Also, you can understand the timing, clinical applications, and limitations of screening tests for Cushing’s disease and how to make a diagnosis as well asmeasurement of canine cortisol for monitoring the treatment of canine adrenal disease. You can still register to join us and Dr Nate Chaudoin tonight at 8 pm (EST) for the free Clinician’s Brief webinar at https://www.bionote.com/events
From 29th to 31th Oct 2022, Bionote Inc. will attend the 47th WSAVA (World Small Animal Veterinary Association Congress & XVIII FIAVAC) Congress in Peru. At WSAVA, you can discover local culture and international perspectives on veterinary medicine. Through the exhibition booth (Booth #9), Bionote Inc. will introduce various products such as Vcheck M10 (POC molecular diagnostic system), C10 (biochemistry), F (Fluorescent immunoassay), and ELISA to veterinary circles and countries around the world and introduce various products that have not yet been released in global countries. Up to now, Bionote Inc. has already released different kinds of products providing unrivaled technology for animal health and diagnosis in the world. Welcome to visit us, talk to our team and learn more about Bionote Inc. during WSAVA. View of Bionote Booth at WSAVA